Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Snap is expected to publicly file its IPO documents any day now, which would start the official clock on an offering that is most likely to occur at the beginning of March. If successful (i.e., raises up to $5 billion at around a $20 billion valuation, and then trades higher), then there will be much rejoicing among Snap execs, employees and venture capitalists.

But that's it. Don't expect Snap to spark a broader tech IPO rally, despite the fever dreams of some in Silicon Valley.

For a startup to have IPO "legs," there need to be other startups with similar characteristics. Snap, however, is unusual for three primary reasons:

  1. Snap is valued more highly than all but three other U.S. startups (Uber, Airbnb and Palantir). That means it won't have any trouble getting analyst coverage (a major challenge for smaller tech companies) and also that it will be attracting deeper institutional pockets than would a much smaller company.
  2. Snap is essentially a consumer-facing social network, in an age when the only other privately-held social network of note (Nextdoor) is exponentially smaller. Other tech companies won't be able pitch mutual funds and hedge funds by saying "We're a lot like Snap."
  3. Snap's user metrics are said to be off-the-charts, particularly in terms of growth. We'll need to wait for the public filing to see validated specifics ― plus how Snap views increasing competition from Instagram ― but almost every one of the company's private investors has privately gushed about these figures (which haven't necessarily translated into revenue... yet).

Moreover, we can look at the recent history. Facebook went public in the second quarter of 2012. Yes the offering had some major hiccups (some of which were Facebook's fault, some not), but the upshot was that fewer companies actually went public in the second half of 2012 than in the first half. Moreover, fewer companies went public on U.S. exchanges in all of 2012 than in 2010 or 2011. Mark Zuckerberg might have made going public cool again, but most founders remained at their less popular tables.

Caveat: 2017 is expected to be a strong year for tech IPOs, but it's correlation to Snap rather than causation. There is a massive glut of VC-backed tech startups on the sidelines, many of which would have priced last year if not for macro factors (e.g., China econ data, Brexit, U.S. presidential election) that scared off their bankers. And a large percentage of this backlog is for enterprise software startups, which means a better bellwether could be AppDynamics (which this morning boosted its proposed offering range, and is expected to price tomorrow night). [Update: Never mind]

Go deeper

Biden says $1,400 stimulus payments can start going out this month

Photo: Samuel Corum/Getty Images

President Biden said Saturday that the Senate passage of his $1.9 trillion COVID relief package means the $1,400 direct payments for most Americans can begin going out later this month.

Driving the news: The Senate voted 50-49 Saturday to approve the sweeping legislation. The House is expected to pass the Senate's version of the bill next week before it heads to Biden's desk for his signature.

7 hours ago - Health

COVID-19 drives smell loss awareness, research

A health worker carries out an olfactory test outside Buenos Aires. Photo: Alejandro Pagni/AFP via Getty Images

The pandemic has thrust a relatively unknown ailment, anosmia — or smell loss — into the international spotlight.

Why it matters: Researchers hope smell testing becomes as standard as the annual flu shot, helping to detect early signs of neurodegenerative diseases like Alzheimer’s and Parkinson’s.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!